🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“This study supports the meaningful survival improvement and manageable safety profile of fruquintinib,” says our Dr. Arvind Dasari of results from the FRESCO-2 trial published in The Lancet. Learn more: fal.cn/3z8B5 Arvind Dasari, MD, MS #ColorectalCancer #EndCancer

New ⁦National Comprehensive Cancer Network (NCCN)⁩ guidelines for Breast/Ovarian/Pancreatic Cancer Genetics posted at nccn.org/professionals/… New recommendation that #PancreaticCancer screening be “considered” for all BRCA2 and ATM pathogenic variant carriers by age 50, even without known family history